Proximity proteomics in a marine diatom reveals a putative cell surface-to-chloroplast iron trafficking pathway

  1. Jernej Turnšek
  2. John K Brunson
  3. Maria del Pilar Martinez Viedma
  4. Thomas J Deerinck
  5. Aleš Horák
  6. Miroslav Oborník
  7. Vincent A Bielinski
  8. Andrew Ellis Allen  Is a corresponding author
  1. Harvard University, United States
  2. University of California San Diego, United States
  3. J. Craig Venter Institute, United States
  4. National Center for Microscopy and Imaging Research, University of California San Diego, United States
  5. Czech Academy of Sciences, Czech Republic
  6. J Craig Venter Institute, United States

Abstract

Iron is a biochemically critical metal cofactor in enzymes involved in photosynthesis, cellular respiration, nitrate assimilation, nitrogen fixation, and reactive oxygen species defense. Marine microeukaryotes have evolved a phytotransferrin-based iron uptake system to cope with iron scarcity, a major factor limiting primary productivity in the global ocean. Diatom phytotransferrin is endocytosed, however proteins downstream of this environmentally ubiquitous iron receptor are unknown. We applied engineered ascorbate peroxidase APEX2-based subcellular proteomics to catalog proximal proteins of phytotransferrin in the model marine diatom Phaeodactylum tricornutum. Proteins encoded by poorly characterized iron-sensitive genes were identified including three that are expressed from a chromosomal gene cluster. Two of them showed unambiguous colocalization with phytotransferrin adjacent to the chloroplast. Further phylogenetic, domain, and biochemical analyses suggest their involvement in intracellular iron processing. Proximity proteomics holds enormous potential to glean new insights into iron acquisition pathways and beyond in these evolutionarily, ecologically, and biotechnologically important microalgae.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files

The following previously published data sets were used

Article and author information

Author details

  1. Jernej Turnšek

    Biological and Biomedical Sciences, The Graduate School of Arts and Sciences, Harvard University, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. John K Brunson

    Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California San Diego, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Maria del Pilar Martinez Viedma

    Microbial and Environmental Genomics, J. Craig Venter Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Thomas J Deerinck

    National Center for Microscopy and Imaging Research, University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Aleš Horák

    Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  6. Miroslav Oborník

    Institute of Parasitology, Biology Centre, Czech Academy of Sciences, České Budějovice, Czech Republic
    Competing interests
    The authors declare that no competing interests exist.
  7. Vincent A Bielinski

    Synthetic Biology and Bioenergy, J Craig Venter Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Andrew Ellis Allen

    Integrative Oceanography Division, Scripps Institution of Oceanography, University of California San Diego, La Jolla, United States
    For correspondence
    aallen@ucsd.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5911-6081

Funding

Gordon and Betty Moore Foundation (GBMF3828)

  • Andrew Ellis Allen

Gordon and Betty Moore Foundation (GBMF5006)

  • Andrew Ellis Allen

National Science Foundation (NSF-OCE-1756884)

  • Andrew Ellis Allen

National Science Foundation (NSF-MCB-1818390)

  • Andrew Ellis Allen

Biological and Environmental Research (DE-SC0018344)

  • Andrew Ellis Allen

Gordon and Betty Moore Foundation (GBMF4958)

  • Jernej Turnšek

National Institutes of Health (1F31ES030613-01)

  • John K Brunson

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Christian S Hardtke, University of Lausanne, Switzerland

Version history

  1. Received: October 16, 2019
  2. Accepted: February 15, 2021
  3. Accepted Manuscript published: February 16, 2021 (version 1)
  4. Accepted Manuscript updated: February 19, 2021 (version 2)
  5. Version of Record published: March 18, 2021 (version 3)

Copyright

© 2021, Turnšek et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,665
    views
  • 366
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jernej Turnšek
  2. John K Brunson
  3. Maria del Pilar Martinez Viedma
  4. Thomas J Deerinck
  5. Aleš Horák
  6. Miroslav Oborník
  7. Vincent A Bielinski
  8. Andrew Ellis Allen
(2021)
Proximity proteomics in a marine diatom reveals a putative cell surface-to-chloroplast iron trafficking pathway
eLife 10:e52770.
https://doi.org/10.7554/eLife.52770

Share this article

https://doi.org/10.7554/eLife.52770

Further reading

    1. Microbiology and Infectious Disease
    Hina Khan, Partha Paul ... Dibyendu Sarkar
    Research Article

    Survival of Mycobacterium tuberculosis within the host macrophages requires the bacterial virulence regulator PhoP, but the underlying reason remains unknown. 3′,5′-Cyclic adenosine monophosphate (cAMP) is one of the most widely used second messengers, which impacts a wide range of cellular responses in microbial pathogens including M. tuberculosis. Herein, we hypothesized that intra-bacterial cAMP level could be controlled by PhoP since this major regulator plays a key role in bacterial responses against numerous stress conditions. A transcriptomic analysis reveals that PhoP functions as a repressor of cAMP-specific phosphodiesterase (PDE) Rv0805, which hydrolyzes cAMP. In keeping with these results, we find specific recruitment of the regulator within the promoter region of rv0805 PDE, and absence of phoP or ectopic expression of rv0805 independently accounts for elevated PDE synthesis, leading to the depletion of intra-bacterial cAMP level. Thus, genetic manipulation to inactivate PhoP-rv0805-cAMP pathway decreases cAMP level, stress tolerance, and intracellular survival of the bacillus.

    1. Biochemistry and Chemical Biology
    2. Microbiology and Infectious Disease
    Natalia E Ketaren, Fred D Mast ... John D Aitchison
    Research Advance

    To date, all major modes of monoclonal antibody therapy targeting SARS-CoV-2 have lost significant efficacy against the latest circulating variants. As SARS-CoV-2 omicron sublineages account for over 90% of COVID-19 infections, evasion of immune responses generated by vaccination or exposure to previous variants poses a significant challenge. A compelling new therapeutic strategy against SARS-CoV-2 is that of single-domain antibodies, termed nanobodies, which address certain limitations of monoclonal antibodies. Here, we demonstrate that our high-affinity nanobody repertoire, generated against wild-type SARS-CoV-2 spike protein (Mast et al., 2021), remains effective against variants of concern, including omicron BA.4/BA.5; a subset is predicted to counter resistance in emerging XBB and BQ.1.1 sublineages. Furthermore, we reveal the synergistic potential of nanobody cocktails in neutralizing emerging variants. Our study highlights the power of nanobody technology as a versatile therapeutic and diagnostic tool to combat rapidly evolving infectious diseases such as SARS-CoV-2.